Véronique PAQUIS-FLUCKLINGER awarded the Prix Claude Pompidou 2024 for her advances in neurodegenerative diseases

0 Comments

In 2024, the Claude Pompidou Prize broadened its scope to include brain pathologies similar to Alzheimer’s disease: Parkinson’s disease, Lewy body dementia, Huntington’s disease, Amyotrophic Lateral Sclerosis (also known as Charcot’s disease) and fronto-temporal lobar degeneration.
This year, the Prize was awarded to the research project led by the team of Pr Véronique Paquis-Flucklinger, Head of the Medical Genetics Department at Nice University Hospital and team leader at the IRCAN.
This prize of €100,000 will enable the acquisition of an automated cellular imaging system, the ImageXpress PICO, to study dysfunctions identified in cellular models much more rapidly and with higher resolution.

Photos ©Ville de Nice / Ghislain MARIETTE.